52
DAFTAR PUSTAKA
1.Datta AK, Saha A, Bhattacharya A, Mandal A, Paul R, Sengupta S. Black cumin (Nigella sativa L) - a review. J Plant Develop Sci 2012; 4(1): 1-5,18.
2.Haloci E, Manfredini S, Toska V, Vertuani S, Ziosi P, Topi I, et al. Antibacterial and antifungal activity assessment of Nigella sativa essential oils. World Acad Sci Eng Technol 2012; 6: 1081-3.
3.Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, et al. A review on therapeutic potential of Nigella sativa : a miracle herb. Asian Pac J Trop Biomed 2013; 3(5): 337-9.
4.Pribadi ER. Pasokan dan permintaan tanaman obat Indonesia serta arah penelitian dan pengembangannya. Perspektif 2009; 8(1): 58-9.
5.Pararakh PM. Nigella sativa Linn - a comprehensive review. Indian J Nat Prod Resour 2010; 1(4): 409-11.
6.Hosseinzadeh H, Bazzar BSF, Haghi MM. Antibacterial activity of total extracts and essential oil of Nigella sativa L seeds in mice. Pharmacolgyonline 2007; 2: 429-30.
7.Gilani AH, Jabeen Q, Khan MAU. A review of medicinal uses and pharmacological activities of Nigella sativa. Pak J Biol Sci 2004; 7(4): 441-4. 8.Mashhadian NV, Rakhshandeh H. Antibacterial and antifungal effects of Nigella
sativa extracts againts S.aureus, P.aeroginosa and C.albicans. Pak J Med Sci 2005; 21(1): 47-51.
9.Al-Khalaf MI, Ramadan KS. Antimicrobial and anticancer activity of Nigella sativa oil - a review. Aust J Basic & Appl Sci 2013; 7(7): 505-7.
10.Raval BP, Shah TG, Suthar MP, Ganure AL. Screening of Nigella sativa seeds for antifungal activity. Ann Biol Res 2010; 1(1): 164-6,171.
11.Rahmawati A, Al-Anwary N, Sasongkowati R. Pengaruh pemberian infusa jintan hitam (Nigella sativa Linn) terhadap pertumbuhan jamur Candida albicans. Analisis Kesehatan Sains 2012; 1(1): 16-20.
53
12.Pinto E, Pina-Vaz C, Salgueiro L, Goncalves MJ, Costa-de-Oliveira S, Cavaleiro C, et al. Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus, and dermatophyte species. J Med Microbiol 2006; 55: 1367-71. 13.Akpan A, Morgan R. Review : oral candidiasis. Postgrad Med J 2002; 78: 455-8. 14.Meurman JH, Siikala E, Richardson M, Rautemaa R. Non-Candida albicans
Candida yeasts of the oral cavity. Formatex 2007; 719-24.
15.Salerno C, Pascale M, Contaldo M, Esposito V, Busciolano M, Milillo L, et al. Candida-associated denture stomatitis. Med Oral Patol Oral Cir Bucal 2011; 16(1): e139-41.
16.Pintauli S, Hamada T. Menuju gigi dan mulut sehat : pencegahan dan pemeliharaan. Edisi revisi. Medan : USU Press, 2014: 42-6.
17.Dangi YS, Soni ML, Namdeo KP. Oral candidiasis : a review. Int J Pharm Pharm Sci 2010; 2(4): 36-7.
18.Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol 2011; 3: 1-3.
19.Bhat V, Sharma SM, Shetty V, Shastry CS, Rao V, Shenoy SM, et al. Prevalence of candida associated denture stomatitis (CADS) and speciation of candida among complete denture wearers of south west coastal region of Karnataka. NUJHS 2013; 3(3): 59-62.
20.Baena-Monroy T, Moreno-Maldonado V, Franco-Martinez F, Aldape-Barrios B, Quindos G, Sanchez-Vargas LO. Candida albicans, Staphylococcus aureus and Streptococcus mutans colonization in patients wearing dental prosthesis. Med Oral Patol Oral Cir Bucal 2005; 10: E27-8.
21.Rajsekhar S, Kuldeep B. Pharmacognosy and pharmacology of Nigella sativa – a review. IRJP 2011; 2(11): 36-7.
22.Chaieb K, Kouidhi B, Jrah H, Mahdouani K, Bakhrouf A. Antibacterial activity of thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complement Altern Med 2011; 1-5.
23.Sulistyawati D, Mulyati S. Uji aktivitas antijamur infusa daun jambu mete (Anacardium occidentale, L) terhadap Candida albicans. Biomedika 2009; 2(1):
54
47-50.
24.EAOM. Denture related stomatitis. http://www.eaom.eu/files/denture_related_ stomatitis.pdf (18 Februari 2015).
25.Samaranayake L. Essential microbiology for dentistry. 4th ed. China : Churchill Livingstone Elsevier, 2012: 54,59,185-7,309-10.
26.Mitchell TG. Medical Mycology. In : Brooks GF, Carroll KC, Butel JS, Morse SA, Mietzner TA. Eds. Jawetz, Melnick, & Adelberg’s Medical Microbiology. 26th ed. USA : Mc Graw Hill Medical, 2013: 694.
27.Musrati ASA. Oral immune defense againts chronic hyperplastic candidosis. Dissertation. Helsinki : University of Helsinki, 2008: 18-9.
28.Tjampakasari CR. Karakteristik Candida albicans. Cermin Dunia Kedokteran 2006; 151: 33-5.
29.American Type Culture Collection. Candida albicans (ATCC® 10231™). https://www.atcc.org/~/ps/10231.ashx (15 Juli 2015).
30.Jumanti D. Media SDA (Soboroud Dextrose Agar). 6 April 2014. http://desijumanti.blogspot.com/2014/04/media-sda-soboroud-dextrose-agar.html (18 Februari 2015).
31.Medical-Labs. Induce chlamydospore formation of Candida albicans using corn meal agar. http://www.medical-labs.net/induce-chlamydospore-formation-of-candida-albicans-using-corn-meal-agar-3019/ (15 Maret 2015).
32.Biswas SK, Chaffin WL. Anaerobic growth of Candida albicans does not support biofilm formation under similar conditions used for aerobic biofilm. Current Microbiology 2005; 51: 100.
33.Kusumaningtyas E. Mekanisme infeksi Candida albicans pada permukaan sel. Lokakarya Nasional Penyakit Zoonosis 2008: 304-7.
34.Hanafiah KA. Rancangan percobaan aplikatif. Jakarta: Graha Wacana, 2005: 12. 35.Spampinato C, Leonardi D. Review article – Candida infections, causes, targets,
and resistance mechanisms : traditional and alternative antifungal agents. BioMed Res Int 2013: 3-5.
36.Kamal A, Arif JM, Ahmad IZ. Potential of Nigella sativa L. seed during different
55
phases of germination on inhibition of bacterial growth. J Biotechnol Pharm Res 2010; 1(1): 009.
37.Zeidan S, Hijazi A, Rammal H, Kobaissi A, Badran B. Extraction of phenolic compounds and flavonoids from Eryngiumcreticum L. by conventional and nonconventional extraction techniques. WJPPS 2014; 3(7): 1897.
38.Sasse C, Hasenberg M, Weyler M, Gunzer M, Morschhauser J. White-opaque switching of Candida albicans allows immune evasion in an environment-dependent fashion. Eukaryot Cell 2012; 12(1): 50.
39.Sanguinetti M, Posteraro B, Lass-Florl C. Antifungal drug resistance among Candida species: mechanisms and clinical impact. Mycoses 2015;58(suppl 2):5-6. 40.Pfaller MA. Antifungal drug resistance : mechanisms, epidemiology, and
consequences for treatment. Am J Med 2012; 125(1A): S7.
